3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and beta-endorphin

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with beta-endorphin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coyne, KE; Farah, JM; Iyengar, S; Mick, SJ; Rao, TS1
Bagdy, G; Calogero, AE; Chrousos, GP; Gold, PW; Gomez, MT; Murphy, DL; Szemeredi, K1

Other Studies

2 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and beta-endorphin

ArticleYear
N-methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat.
    Endocrinology, 1991, Volume: 128, Issue:4

    Topics: Adrenocorticotropic Hormone; Animals; beta-Endorphin; Corticosterone; Dexamethasone; Kinetics; Luteinizing Hormone; Male; N-Methylaspartate; Piperazines; Pituitary Gland; Rats; Receptors, N-Methyl-D-Aspartate

1991
Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action.
    Brain research, 1990, Dec-24, Volume: 537, Issue:1-2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Arginine Vasopressin; beta-Endorphin; Cells, Cultured; Corticotropin-Releasing Hormone; Dexamethasone; Male; Piperazines; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Serotonin; Tetrahydronaphthalenes; Vasopressins

1990